537 related articles for article (PubMed ID: 28096702)
41. Prebiotics in infant formulas.
Boehm G; Jelinek J; Stahl B; van Laere K; Knol J; Fanaro S; Moro G; Vigi V
J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S76-9. PubMed ID: 15220664
[TBL] [Abstract][Full Text] [Related]
42. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants.
Langhendries JP; Detry J; Van Hees J; Lamboray JM; Darimont J; Mozin MJ; Secretin MC; Senterre J
J Pediatr Gastroenterol Nutr; 1995 Aug; 21(2):177-81. PubMed ID: 7472904
[TBL] [Abstract][Full Text] [Related]
43. Microbiome Composition in Pediatric Populations from Birth to Adolescence: Impact of Diet and Prebiotic and Probiotic Interventions.
Davis EC; Dinsmoor AM; Wang M; Donovan SM
Dig Dis Sci; 2020 Mar; 65(3):706-722. PubMed ID: 32002758
[TBL] [Abstract][Full Text] [Related]
44. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides.
Schmelzle H; Wirth S; Skopnik H; Radke M; Knol J; Böckler HM; Brönstrup A; Wells J; Fusch C
J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):343-51. PubMed ID: 12604972
[TBL] [Abstract][Full Text] [Related]
45. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants.
Scalabrin DM; Mitmesser SH; Welling GW; Harris CL; Marunycz JD; Walker DC; Bos NA; Tölkkö S; Salminen S; Vanderhoof JA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):343-52. PubMed ID: 21946836
[TBL] [Abstract][Full Text] [Related]
46. The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.
Martín-Peláez S; Cano-Ibáñez N; Pinto-Gallardo M; Amezcua-Prieto C
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057522
[TBL] [Abstract][Full Text] [Related]
47. Effect of Formula Containing Lactobacillus reuteri DSM 17938 on Fecal Microbiota of Infants Born by Cesarean-Section.
Garcia Rodenas CL; Lepage M; Ngom-Bru C; Fotiou A; Papagaroufalis K; Berger B
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):681-687. PubMed ID: 27035371
[TBL] [Abstract][Full Text] [Related]
48. Gut microbiota comparison of vaginally and cesarean born infants exclusively breastfed by mothers secreting α1-2 fucosylated oligosaccharides in breast milk.
Tonon KM; Morais TB; Taddei CR; Araújo-Filho HB; Abrão ACFV; Miranda A; de Morais MB
PLoS One; 2021; 16(2):e0246839. PubMed ID: 33556125
[TBL] [Abstract][Full Text] [Related]
49. Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial.
Bosheva M; Tokodi I; Krasnow A; Pedersen HK; Lukjancenko O; Eklund AC; Grathwohl D; Sprenger N; Berger B; Cercamondi CI;
Front Nutr; 2022; 9():920362. PubMed ID: 35873420
[TBL] [Abstract][Full Text] [Related]
50. Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula.
Oswari H; Prayitno L; Dwipoerwantoro PG; Firmansyah A; Makrides M; Lawley B; Kuhn-Sherlock B; Cleghorn G; Tannock GW
J Paediatr Child Health; 2013 Dec; 49(12):1032-9. PubMed ID: 23782263
[TBL] [Abstract][Full Text] [Related]
51. Cesarean Section, Formula Feeding, and Infant Antibiotic Exposure: Separate and Combined Impacts on Gut Microbial Changes in Later Infancy.
Yasmin F; Tun HM; Konya TB; Guttman DS; Chari RS; Field CJ; Becker AB; Mandhane PJ; Turvey SE; Subbarao P; Sears MR; ; Scott JA; Dinu I; Kozyrskyj AL
Front Pediatr; 2017; 5():200. PubMed ID: 29018787
[TBL] [Abstract][Full Text] [Related]
52. Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas.
Velaphi SC; Cooper PA; Bolton KD; Mokhachane M; Mphahlele RM; Beckh-Arnold E; Monaheng L; Haschke-Becher E
Nutrition; 2008 Mar; 24(3):203-11. PubMed ID: 18160258
[TBL] [Abstract][Full Text] [Related]
53. Integrated Role of
He X; Slupsky CM; Dekker JW; Haggarty NW; Lönnerdal B
mSystems; 2016; 1(6):. PubMed ID: 27921083
[TBL] [Abstract][Full Text] [Related]
54. Normal growth of infants receiving an infant formula containing Lactobacillus reuteri, galacto-oligosaccharides, and fructo-oligosaccharide: a randomized controlled trial.
Lee le Y; Bharani R; Biswas A; Lee J; Tran LA; Pecquet S; Steenhout P
Matern Health Neonatol Perinatol; 2015; 1():9. PubMed ID: 27057326
[TBL] [Abstract][Full Text] [Related]
55. Safety, growth, and support to healthy gut microbiota by an infant formula enriched with functional compounds.
Civardi E; Garofoli F; Longo S; Mongini ME; Grenci B; Mazzucchelli I; Angelini M; Castellazzi A; Fasano F; Grinzato A; Fanos V; Budelli A; Stronati M
Clin Nutr; 2017 Feb; 36(1):238-245. PubMed ID: 26718667
[TBL] [Abstract][Full Text] [Related]
56. Gut Bifidobacterium microbiota in one-month-old Brazilian newborns.
Grześkowiak Ł; Sales Teixeira TF; Bigonha SM; Lobo G; Salminen S; Ferreira CL
Anaerobe; 2015 Oct; 35(Pt B):54-8. PubMed ID: 26204793
[TBL] [Abstract][Full Text] [Related]
57. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany.
Grześkowiak Ł; Grönlund MM; Beckmann C; Salminen S; von Berg A; Isolauri E
Anaerobe; 2012 Feb; 18(1):7-13. PubMed ID: 21979491
[TBL] [Abstract][Full Text] [Related]
58. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
[TBL] [Abstract][Full Text] [Related]
59. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.
Vlieger AM; Robroch A; van Buuren S; Kiers J; Rijkers G; Benninga MA; te Biesebeke R
Br J Nutr; 2009 Sep; 102(6):869-75. PubMed ID: 19331702
[TBL] [Abstract][Full Text] [Related]
60. Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity.
Yao M; Lien EL; Capeding MR; Fitzgerald M; Ramanujam K; Yuhas R; Northington R; Lebumfacil J; Wang L; DeRusso PA
J Pediatr Gastroenterol Nutr; 2014 Oct; 59(4):440-8. PubMed ID: 24840511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
